Related Experiment Video
Updated: Sep 19, 2025

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
Gi-DREADD activation decreases Epithelial Na+ channel activity in renal principal cells
Tarek Mohamed Abd El-Aziz1, Elena Mironova2, James D Stockand3
1Zoology Department, Faculty of Science, Minia University, Minya, Egypt.
Abstract:
The activity of the Epithelial Na+ Channel (ENaC) in renal principal cells (PC) fine-tunes sodium excretion and consequently affects blood pressure. G-coupled receptors play an important role in regulating ENaC activity. We previously explored the role of Gq and Gs in regulating ENaC activity by using the designer receptors exclusively activated by designer drugs (DREADD) technology. We demonstrated that pharmacogenetic activation of Gq (Gq-DREADD) exclusively in principal cells by Clozapine-N-oxide (CNO) reduced ENaC activity in renal tubules, promoting natriuresis that lowered elevated blood pressure in the DOCA-salt model of hypertension. In addition, by investigating the Gs-adenylyl cyclase-cAMP signal transduction pathway, we exhibited that treatment of PC-specific Gs-DREADD mice with CNO rapidly and significantly decreased urinary Na+ excretion. In this study, we investigate the role of Gi-DREADD in regulating ENaC activity. Our results showed that Gi-DREADD, expressed exclusively in renal principal cells, activated by CNO reduced ENaC activity and significantly increased urinary Na+ excretion compared to CNO-treated littermates. These findings provide for the first time that target activation of Gi signaling exclusively in PCs is sufficient to decrease ENaC activity and increase dependent urinary Na+ excretion in live animals.
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Antihypertensive Drugs: Action of Diuretics
Antihypertensive Drugs: Thiazide-Class Diuretics
Hormonal Regulation
Reabsorption and Secretion in the DCT and Collecting Duct
The distal...
Antihypertensive Drugs: Direct Renin Inhibitors

